Abstract:Human full-length (fl) αSyn fibrils, key neuropathological hallmarks of Parkinson's disease (PD), generate intense optical activity in correspondence of the surface plasmon resonance of interacting gold nanorods. Here, we analysed fibril-enriched protein extracts from mouse and human brain samples as well as from SK-N-SH cell lines with or without human fl and C-terminally truncated (Ctt) αSyn overexpression and exposed to αSyn monomers, recombinant fl or Ctt αSyn fibrils. In vitro-generated human recombinant fl and Ctt αSyn fibrils and fibrils purified from SK-N-SH cells with fl or Ctt αSyn overexpression were also analysed by transmission electron microscopy (TEM) to gain insight into the nanorod-fibril complexes. We found that, under the very same experimental conditions, bisignate circular dichroism (CD) spectra of Ctt αSyn fibrils always exhibited a wavelength blue shift when compared to fl αSyn. TEM supported that this could be ascribed to the different disposition of nanorods. In our experimental conditions, the fibril-enriched PD brain extract produced broadening of the longitudinal surface plasmonic band with a bisignate CD couplet centred in correspondence of the absorption band maximum. Plasmonic CD (PCD) couplets of in vivo- and in vitro-generated fibrils displayed sign reversal suggestive of opposite handedness. Moreover, incubation of in vitro-generated human recombinant fl αSyn fibrils in mouse brain extracts from αSyn null mice resulted in PCD couplet inversion, hinting that biological environment may shape αSyn fibril handedness. These findings support that nanorod-based PCD can provide useful information on the composition and features of αSyn fibrils from biological material.

Correction: Nanorod-associated plasmonic circular dichroism monitors the handedness and composition of α-synuclein fibrils from Parkinson's disease models and post-mortem brain

Nanorod-associated plasmonic circular dichroism monitors the handedness and composition of α-synuclein fibrils from Parkinson's disease models and post-mortem brain

Correction: Chiral Se@CeO 2 superparticles for ameliorating Parkinson's disease

Correction: Enhanced Photoluminescence of Silicon Quantum Dots in the Presence of Both Energy Transfer Enhancement and Emission Enhancement Mechanisms Assisted by the Double Plasmon Modes of Gold Nanorods

Plasmon-enhanced Luminescence in Novel Complex Conjugated Polymer Nanoparticles: Publisher’s Note

Correction: Application of Carbon-Based Nanomaterials in Alzheimer's Disease.

Correction: Surface-enhanced Raman Spectroscopy for Bioanalysis and Diagnosis

Correction: Carbon dots with tunable dual emissions: from the mechanism to the specific imaging of endoplasmic reticulum polarity

Correction: Ordered nanoparticle arrays interconnected by molecular linkers: electronic and optoelectronic properties.

Author Correction: Reversing a model of Parkinson’s disease with in situ converted nigral neurons

Corrigendum: Plasmonic/Nonlinear Optical Material Core/Shell Nanorods As Nanoscale Plasmon Modulators and Optical Voltage Sensors

Berichtigung: Custom‐Made Ceria Nanoparticles Show a Neuroprotective Effect by Modulating Phenotypic Polarization of the Microglia

Detection of amyloid fibrils in Parkinson’s disease using plasmonic chirality

Author correction to ‘A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer’s disease’ [Acta Pharmaceutica Sinica B 12 (2021) 4032‒4044]

Correction: Plasmon enhanced light–matter interaction of rice-like nanorods by a cube-plate nanocavity

Correction: New horizons on advanced nanoscale materials for Cultural Heritage conservation

Correction: Spin-dependent Seebeck effect in zigzag-edge antimonene nanoribbons

Correction: Ce6-Conjugated and Polydopamine-Coated Gold Nanostars with Enhanced Photoacoustic Imaging and Photothermal/photodynamic Therapy to Inhibit Lung Metastasis of Breast Cancer.

Correction: Nanoporous hybrid CuO/ZnO/carbon papers used as ultrasensitive non-enzymatic electrochemical sensors

Correction: Musumeci et al. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer's Disease. Biomedicines 2022, 10, 985

Correction to "Photothermal Microscopy and Spectroscopy with Nanomechanical Resonators"